Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07283315 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases

StatusRecruiting
PhaseEarly Phase 1
Started2025-12-03
View on ClinicalTrials.gov ↗

Amendment history

2026-01-31
minor
Study Status v1
Re-verified, no change to tracked fields
2025-12-02
minor
Original filing
Evaluating the efficacy and safety of anti-CD19/BCMA CAR-NK Cells in Paediatric B cell-related autoimmune diseases
Trial Details
NCT Number NCT07283315
Lead Sponsor The Children's Hospital of Zhejiang University School of Medicine
Collaborators: Rui Therapeutics
Conditions Paediatric B Cell-related Autoimmune Diseases, Autoimmune Diseases, CAR
Enrollment 12 participants
Start Date 2025-12-03
Primary Completion 2028-12-30 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-03